IL43723A - 2-phenyl(or pyridyl)-2,3,5,6-tetrahydro imidazo(2,1-b)thiazole derivatives,process for the preparation thereof and pharmaceutical compositions containing them - Google Patents

2-phenyl(or pyridyl)-2,3,5,6-tetrahydro imidazo(2,1-b)thiazole derivatives,process for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
IL43723A
IL43723A IL43723A IL4372373A IL43723A IL 43723 A IL43723 A IL 43723A IL 43723 A IL43723 A IL 43723A IL 4372373 A IL4372373 A IL 4372373A IL 43723 A IL43723 A IL 43723A
Authority
IL
Israel
Prior art keywords
pyridyl
phenyl
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL43723A
Other languages
English (en)
Other versions
IL43723A0 (en
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7242580A external-priority patent/FR2207708A1/fr
Priority claimed from FR7335158A external-priority patent/FR2245348A1/fr
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of IL43723A0 publication Critical patent/IL43723A0/xx
Publication of IL43723A publication Critical patent/IL43723A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL43723A 1972-11-30 1973-11-29 2-phenyl(or pyridyl)-2,3,5,6-tetrahydro imidazo(2,1-b)thiazole derivatives,process for the preparation thereof and pharmaceutical compositions containing them IL43723A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7242580A FR2207708A1 (en) 1972-11-30 1972-11-30 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity
FR7335158A FR2245348A1 (en) 1973-10-02 1973-10-02 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity

Publications (2)

Publication Number Publication Date
IL43723A0 IL43723A0 (en) 1974-03-14
IL43723A true IL43723A (en) 1976-07-30

Family

ID=26217429

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43723A IL43723A (en) 1972-11-30 1973-11-29 2-phenyl(or pyridyl)-2,3,5,6-tetrahydro imidazo(2,1-b)thiazole derivatives,process for the preparation thereof and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4005212A (fr)
JP (1) JPS5314077B2 (fr)
AR (1) AR203186A1 (fr)
AT (1) AT329554B (fr)
BE (1) BE808008A (fr)
CA (1) CA1002955A (fr)
CH (1) CH579577A5 (fr)
DD (1) DD107697A5 (fr)
DE (1) DE2359864A1 (fr)
DK (1) DK136823B (fr)
ES (1) ES421011A1 (fr)
GB (1) GB1404708A (fr)
HU (1) HU167368B (fr)
IE (1) IE38552B1 (fr)
IL (1) IL43723A (fr)
LU (1) LU68887A1 (fr)
NL (1) NL7316016A (fr)
OA (1) OA04567A (fr)
SE (1) SE399894B (fr)
SU (1) SU518133A3 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179460A (en) * 1977-07-06 1979-12-18 Dso "Pharmachim" Derivatives of R,S-[X2-(2-hydroxyethylamino)-1-phenyl]-ethylamine, and process
US4370482A (en) 1978-02-15 1983-01-25 American Cyanamid Co. Synthesis of tetramisole, levamisole and their derivatives
US4620009A (en) * 1980-03-17 1986-10-28 Cyanamid Agricultural De Puerto Rico, Inc. Synthesis of intermediates for tetramisole, levamisole and their derivatives
ZA827736B (en) * 1981-11-25 1983-08-31 Pfizer Bicyclic imidazole and imidazolines as ectoparasiticides and anthelmintics
EP0103830A3 (fr) * 1982-09-22 1985-07-31 Bayer Ag Dérivés de phényléthylamine comme stimulateurs de croissance
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU409983B2 (en) * 1965-07-19 1970-12-31 Imperial Chemical Industries Of Australia New Zealand Limited Process for the manufacture of thia zolidines and thiazolidines produced thereby

Also Published As

Publication number Publication date
DE2359864A1 (de) 1974-06-06
JPS5314077B2 (fr) 1978-05-15
HU167368B (fr) 1975-09-27
IE38552B1 (en) 1978-04-12
US4005212A (en) 1977-01-25
CH579577A5 (fr) 1976-09-15
IE38552L (en) 1974-05-30
NL7316016A (fr) 1974-06-04
AU6300973A (en) 1975-05-29
DD107697A5 (fr) 1974-08-12
BE808008A (fr) 1974-05-29
ES421011A1 (es) 1976-06-16
OA04567A (fr) 1980-05-31
AR203186A1 (es) 1975-08-22
LU68887A1 (fr) 1974-07-05
ATA1005173A (de) 1975-08-15
DK136823B (da) 1977-11-28
CA1002955A (fr) 1977-01-04
DK136823C (fr) 1978-05-08
GB1404708A (en) 1975-09-03
IL43723A0 (en) 1974-03-14
SE399894B (sv) 1978-03-06
JPS4993390A (fr) 1974-09-05
AT329554B (de) 1976-05-25
SU518133A3 (ru) 1976-06-15

Similar Documents

Publication Publication Date Title
SE402592B (sv) Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner
IL41232A (en) Pyrrolo(3,4-b)pyrazine derivatives,processes for their preparation and pharmaceutical preparations containing the same
IL57541A0 (en) 7-oxo- -4-thia-2,6-diazabicyclo(3,2,0)heptene derivatives,process for their preparation and pharmaceutical compositons comprising the same
CA1005061A (en) Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
CA1016544A (en) Process for the preparation of bicyclic derivatives of 1,4-dihydropyridine
ZA727074B (en) Process for the preparation of 3,4,5-trimethoxybenzaldehyde
IL46000A0 (en) Thiazoline derivatives,processes for the production thereof and pharmaceutical compositions containing the same
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL43723A (en) 2-phenyl(or pyridyl)-2,3,5,6-tetrahydro imidazo(2,1-b)thiazole derivatives,process for the preparation thereof and pharmaceutical compositions containing them
IL44815A0 (en) Naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL43734A0 (en) 1,4-dithiino(2,3-c)pyrrole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL45950A0 (en) 2-aminothiazole derivatives,their preparation and pharmaceutical compositions containing them
CA960655A (en) N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
IL41350A (en) Indole-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL46040A0 (en) Cephalosporin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL40807A (en) Heterocyclic-substituted nebularin derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
AU5590073A (en) 6-methylprednisolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same
IL42309A0 (en) New heterocyclic derivatives,preparation process and pharmaceutical compositions
IL39337A0 (en) Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same
NL149082B (nl) Werkwijze ter bereiding van farmaceutische preparaten, gevormde preparaten en werkwijze ter bereiding van daarvoor geschikte thiazolino (3,2-a)-5-pyrimidinonderivaten.
IL42179A0 (en) Cyclopentenoquinolone derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA998677A (en) Process for the preparation of 2-substituted-1,3,4-thiadiazole-5-thiols
IL44451A0 (en) 1,2-diphenyl-ethane derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
IL40639A0 (en) Novel nitrofuran derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL37609A0 (en) Novel benzodiazepine derivatives,processes for their preparation and pharmaceutical compositions containing the same